|
已读[64]
发布： 2013/10/08 16:30:48
MarketWatch Patients treated with dapagliflozin 10 mg as an add-on therapy to metformin plus sulfonylurea demonstrated significant improvements in glycosylated hemoglo...
|
|
|
|
|
已读[72]
发布： 2013/10/08 16:30:21
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ... and more »
|
|
|
|
|
已读[65]
发布： 2013/10/07 16:34:53
MarketWatch Patients treated with dapagliflozin 10 mg as an add-on therapy to metformin plus sulfonylurea demonstrated significant improvements in glycosylated hemoglo...
|
|
|
|
|
已读[61]
发布： 2013/10/07 16:34:28
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ... and more »
|
|
|
|
|
已读[70]
发布： 2013/10/06 16:30:21
The Providence Journal BURLINGTON, Mass., Oct. 2, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through analysis of U.S. longitudinal patient-level claims data, dipeptidyl ...
|
|
|
|
|
已读[65]
发布： 2013/10/06 16:30:16
MarketWatch Patients treated with dapagliflozin 10 mg as an add-on therapy to metformin plus sulfonylurea demonstrated significant improvements in glycosylated hemoglo...
|
|
|
|
|
已读[62]
发布： 2013/10/06 16:29:50
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ... and more »
|
|
|
|
|
已读[59]
发布： 2013/10/05 16:32:52
The Providence Journal BURLINGTON, Mass., Oct. 2, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through analysis of U.S. longitudinal patient-level claims data, dipeptidyl ...
|
|
|
|
|
已读[68]
发布： 2013/10/05 16:32:26
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ... and more »
|
|
|
|
|
已读[67]
发布： 2013/10/04 16:30:07
PR Newswire (press release) BURLINGTON, Mass., Oct. 2, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through analysis of U.S. longitudinal patient-level claims data, dipeptidyl ...
|
|
|
« 上一页 |
查看结果401-410共686
|
下一页 »
|
|
